Wild-type mice control murine cytomegalovirus (MCMV) brain infection, but identical infection is lethal to animals deficient in interleukin (IL)-10. Here, we report that MCMV-infected IL-10 knockout (KO) mice displayed a marked increase in neutrophil infiltration into the infected, IL-10-deficient brain when compared to wild-type animals. Enhanced microglial cell activation, determined by MHC class II up-regulation, overexpression of CXCL2, and elevated P-selectin mRNA levels were observed. In vivo blocking of CXCL2 attenuated neutrophil infiltration and significantly improved the outcome of infection. Collectively, these data indicate that the absence of IL-10 results in pathologic neutrophil infiltration into MCMV-infected brains.
Introduction
IL-10 is a prototypical anti-inflammatory cytokine that suppresses cellular immunity and inhibits the synthesis and release of proinflammatory mediators (Howard et al., 1992; Moore et al., 2001 ). In the central nervous system, IL-10 has been shown to improve outcomes in models of stroke (Dietrich et al., 1999) and experimental autoimmune encephalomyelitis (Zhang et al., 2004) . We have recently shown that absence of this single cytokine turns a benign MCMV brain infection lethal, without increased viral load in the brain (Cheeran et al., 2007) . Lethal MCMV brain infection is associated with elevated levels of cytokines and chemokines, especially IFN-γ, and the IFN-γ-inducible chemokines CXCL9 and CXCL10 (Cheeran et al., 2007) . Paradoxically, despite elevated cytokine and chemokine levels in the brain following MCMV infection of IL-10 deficient mice there is reduced lymphocyte infiltration (Cheeran et al., 2009) .
IL-10 exerts a wide spectrum of biological activities implicated in the regulation of inflammatory and immune responses. Among the different cell types affected by interleukin-10, monocyte/macrophages and lymphocytes appear to be particularly modified with regard to their function, morphology, and phenotype (Cassatella, 1998) . One of the main functions of anti-inflammatory cytokines such as IL-10 is thought to be their role as a host mechanism to limit tissue damage and turn off proinflammatory responses (Mills, 2004) . Because resident glial cells and infiltrating lymphocytes communicate through cytokine and chemokine mediators, the well-documented neuroprotective action of anti-inflammatory cytokines is likely related to their ability to inhibit chemokine-driven neuroinflammation.
The recruitment of specific leukocyte subsets from the periphery into distinct tissues is mediated by sequential interaction of different adhesion and signaling molecules on leukocytes and the endothelial cells lining the vessel walls (Luster et al., 2005) . CXCL2 (a homologue of human IL-8 or MIP-2β) is a member of the C-X-C chemokine family. Although the role of CXCL2 in neuroinflammation is poorly understood, studies have demonstrated that CXCL2 is a potent chemoattractant and activator of neutrophils (Yoshimura et al., 1987) . This activation may result in increased respiratory burst activity, production of bioactive lipids, and release of lysosomal enzymes, potentially contributing to tissue injury (Baggiolini et al., 1994; Harada et al., 1996) . CXCL2 also regulates neutrophil adhesion to endothelial cells (Huber et al., 1991) , facilitating tissue infiltration of these cells.
Microglial cells and astrocytes are the key sources of CXCL2 within the brain (Babcock et al., 2003; Rubio et al., 2006) . Mononuclear phagocytes are activated following viral infection and produce a wide variety of cytokines and chemokines, which may either play a protective role or initiate exaggerated immune responses (Cheeran et al., 2001) . Previous studies from our laboratory have shown that there is heightened neuroinflammation and altered lymphocyte recruitment during MCMV brain infection in the context of IL-10 deficiency (Cheeran et al., 2007 (Cheeran et al., , 2009 ). In addition to producing chemokines which attract lymphocytes, activation of microglial cells may also be a key component that induces influx of neutrophils. Furthermore, CXCL2 is found in the brain during viral infections (Rubio et al., 2006) , and antibody neutralization of CXCL2 can alter the host response in models of both viral (Yan et al., 1998) and bacterial (Greenberger et al., 1996; Kernacki et al., 2000) infection. In this Journal of Neuroimmunology 227 (2010) [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] 
